SMA News Today

ZOLGENSMA Is The 2nd FDA Approved Treatment For SMA & Speech Generating Devices For Children

ZOLGENSMA Is The 2nd FDA Approved Treatment For SMA & Speech Generating Devices For Children

SMA News Today’s Director of Multichannel Content, Michael Morale, reads from an article published on the SMA News Today website regarding the official approval of ZOLGENSMA as the 2nd FDA approved treatment for spinal muscular atrophy. Also, we discuss a parent survey that showed how speech generating devices provide benefits for children with SMA Type 1. Link to article regarding FDA approval of ZOLGENSMA: https://smanewstoday.com/2019/05/24/fda-approves-zolgensma-gene-therapy-newborns-toddlers-with-any-sma-type/ Are you interested in understanding gene therapy? ExploreGeneTherapy.com has helpful information about gene therapy, including its history and how it is being investigated for the treatment of genetic diseases. Visit www.exploregenetherapy.com

Duration: 17 min

Release Date:

Share part or all of the audio of this episode